Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients
Authors:
- 17 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 99, 30-37
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 29 references indexed in Scilit:
- Uric acid and xanthine oxidase in heart failure — Emerging data and therapeutic implicationsInternational Journal of Cardiology, 2016
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure PatientsCirculation, 2015
- Prognostic Value of Uric Acid in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary InterventionThe American Journal of Cardiology, 2012
- The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCIAtherosclerosis, 2011
- Hyperuricemia and the Echocardiographic Measures of Myocardial DysfunctionCongestive Heart Failure, 2011
- Uric Acid as a Predictor of All-Cause Mortality in Heart Failure: A Meta-AnalysisCongestive Heart Failure, 2011
- Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: Its prognostic role and relation with inflammatory markersInternational Journal of Cardiology, 2010
- Impact of Oxypurinol in Patients With Symptomatic Heart FailureJACC, 2008
- Prognostic Usefulness of Serum Uric Acid After Acute Myocardial Infarction (The Japanese Acute Coronary Syndrome Study)The American Journal of Cardiology, 2005
- Increased Urinary Loss of Uric Acid in Adults with Acute Respiratory Failure Requiring Mechanical VentilationChest, 1992